An electrocardiographic series of flecainide toxicity

Anti-arrhythmic drugs (AADs) uniquely affect the various electrolyte channels in the heart and can slow conduction, increase refractoriness, and/or decrease automaticity with the goal of preventing tachyarrhythmias. Due to these properties, these same drugs are by nature pro-arrhythmic. Vaughan-Will...

Full description

Saved in:
Bibliographic Details
Published in:Indian pacing and electrophysiology journal 2019-03, Vol.19 (2), p.75-78
Main Authors: Smith, Alexandra, Gerasimon, Gregg
Format: Article
Language:English
Subjects:
Antiarrhythmic drugs
Atrial fibrillation
Case Report
Flecainide
Toxicity
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Anti-arrhythmic drugs (AADs) uniquely affect the various electrolyte channels in the heart and can slow conduction, increase refractoriness, and/or decrease automaticity with the goal of preventing tachyarrhythmias. Due to these properties, these same drugs are by nature pro-arrhythmic. Vaughan-Williams classification Ic AADs belong to a class of medications that inhibit sodium channels, leading to decreased conduction velocity of myocytes and Purkinje fibers as well as to decreased automaticity of pacemaker cells. When present in toxic amounts, this leads to classic changes on the electrocardiogram (ECG) that are harbingers of potentially lethal arrhythmias. Presented is a clinical series of ECGs that occurred in a patient who presented with flecainide toxicity.
ISSN:0972-6292
0972-6292
DOI:10.1016/j.ipej.2018.11.012